In the AUDACITY trial, 58% of patients using the Allurion Balloon achieved at least a 5% total body weight loss at 48 weeks. The Food and Drug Administration (FDA) has approved Allurion Gastric ...

Lanreotide-octreotide switch in advanced gastrointestinal neuroendocrine tumors (giNETs). Retreatment patterns and outcomes in patients (pts) with gastroenteropancreatic neuroendocrine tumors ...

Allurion has received the US Food and Drug Administration (FDA) clearance for premarket approval (PMA) application for its Gastric Balloon System featuring the Allurion Smart Capsule for obesity ...

Studies have reported cases of people developing autoimmune diseases like rheumatoid arthritis and lupus after undergoing gastric bypass surgery. But research is mixed as to whether there’s a link.

ReShape Lifesciences® announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent covering an innovative intragastric balloon system with a swallowable ...

Digestive health usually goes unnoticed until discomfort strikes. But it lays the foundation of overall well-being, supporting immunity, nutrient absorption, and even mental stability. A 2023 survey ...